Clinical Trials Logo
  1. Home
  2. Osteoporosis
  3. NCT02156999
  4. Details
NCT02156999 Clinical Trial

Changes of Bone Turnover Markers and Bone Mineral Density After Osteoporosis Treatment

Osteoporosis Clinical Trial

Official title:
Changes of Bone Turnover Markers and Bone Mineral Density After Treatment in Osteoporotic Patients

Clinical Trial Details — Status: Recruiting

Administrative data
NCT number NCT02156999
Other study ID # IB2014
Secondary ID
Status Recruiting
Phase Phase 4
First received
Last updated
Start date June 2014
Est. completion date December 2025

Study information
Verified date September 2021
Source Shinshu University
Contact Yukio Nakamura, MD, PhD
Phone +81-263-37-2659
Email yxn14@aol.jp
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

To examine the changes of bone mineral density and bone turnover markers after Bonviva treatment in osteoporotic patients

Recruitment information / eligibility
Status Recruiting
Enrollment 100
Est. completion date December 2025
Est. primary completion date October 2022
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 20 Years to 100 Years
Eligibility Inclusion Criteria: - Osteoporosis Exclusion Criteria: - Kidney, parathyroid, congenital bone metabolic disease

Study Design

Related Conditions & MeSH terms

Intervention

Device:
• Ibandronic acid, vitamin D

Locations
Country Name City State
Japan Showa Inan General Hospital Komagane Nagano

Sponsors (1)
Lead Sponsor Collaborator
Shinshu University

Country where clinical trial is conducted

Japan, 

Outcome
Type Measure Description Time frame Safety issue
Primary Changes of bone mineral density To examine the changes of bone mineral density for the purpose of the effectiveness of the drug every 4-6 months
Secondary Improvement of bone turnover markers To examine the changes of bone turnover markers for the purpose of the effectiveness of the drug Every 3-6 months
See also
  Status Clinical Trial Phase
Active, not recruiting NCT06287502 - Efficacy of Structured Exercise-Nutritional Intervention on Sarcopenia in Patients With Osteoporosis N/A
Completed NCT03822078 - Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Denosumab (AMG 162) in Japanese Postmenopausal Women Phase 1
Recruiting NCT05845021 - Surgeon-Initiated Bone Health Referral Pathway in Patients Undergoing Lower Extremity Arthroplasty N/A
Completed NCT00092066 - A Study to Evaluate the Safety, Tolerability, and Efficacy of an Investigational Drug and Dietary Supplement in Men and Postmenopausal Women With Osteoporosis (0217A-227) Phase 3
Recruiting NCT04754711 - Interest of Nutritional Care of Children With Sickle Cell Disease on Bone Mineral Density and Body Composition N/A
Completed NCT04736693 - Replication of the HORIZON Pivotal Fracture Trial in Healthcare Claims Data
Not yet recruiting NCT06431867 - Primary Care Management of Osteoporosis in Older Women
Completed NCT02922478 - Role of Comorbidities in Chronic Heart Failure Study
Recruiting NCT02616627 - Association Between DXA Results and the Complications, Clinical Courses and Outcomes in Chronic Dialysis Patients
Recruiting NCT02635022 - Fragility Fracture Liaison Service and Anti-osteoporosis Medication Monitoring Service Study
Active, not recruiting NCT02617303 - Prevention of Falls and Its Consequences in Elderly People N/A
Completed NCT02566655 - Clinical Trial of Intravenous Infusion of Fucosylated Bone Marrow Mesenchyme Cells in Patients With Osteoporosis Phase 1
Not yet recruiting NCT02223572 - Secondary Fracture Prevention in Patients Who Suffered From Osteoporotic Fracture N/A
Completed NCT03420716 - Symbiotic Yogurt, Calcium Absorption and Bone Health in Young Adult Women N/A
Completed NCT02559648 - Denosumab vs Placebo in Patients With Thalassemia Major and Osteoporosis Phase 2
Not yet recruiting NCT01854086 - Compliance and Persistence With Osteoporosis Treatment and Attitude Towards Future Therapy Among Post-menopausal Israeli Women During Drug Treatment or Drug Holiday N/A
Completed NCT02003716 - DeFRA Questionnaire as an Anamnestic Form N/A
Unknown status NCT01913834 - Nasally and sc Administered Teriparatide in Healthy Volunteers Phase 1
Completed NCT01401556 - C-STOP Fracture Trial N/A
Completed NCT01757340 - Calorie Restriction With Leucine Supplementation N/A